About
Publications
Onco’Zine
The Onco’Zine Brief
The Onco’Zine Dossier
Episodes
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
Advisory Board
Join Our Editorial Advisory Board
Call for Papers
Submission Guidelines
Instructions for Authors: Introduction
Step 1: Before You Begin the Submission Process
Step 2: Prepare to Submit Your Manuscript
2020 Media Kit
Sponsors
Partners
Feedback
Subscribe
Contact
Articles
Editorial
News
Business & Economics
Conference Coverage
Must Read Articles
Clinical Trials Update
Peer Review
The Review
ADC Directory
Join Today
Video Library
Resources
ADC Drug Map
Resources for Clinicians
ADC Package Inserts
Clinical Trials
ADC University
Recommended Reading
ADC Review | The Bookstore
ADC Review | The Bookstore – Lyophilization of Pharmaceuticals and Biologicals
ADC Review | The Bookstore – Bioconjugation: Methods and Protocols
ADC Review | The Bookstore – Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes
ADC Review | The Bookstore – Analytical Characterization of Biotherapeutics
ADC Review | The Bookstore – Antibody Drug Discovery | Molecular Medicine and Medicinal Chemistry
ADC Review | The Bookstore – Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
ADC Review | The Bookstore – Antibody-Drug Conjugates Methods in Molecular Biology
ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
ADC Review | The Bookstore – Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer 1st Edition
ADC Review | The Bookstore – Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications
ADC Review | The Bookstore – Antibody-Drug Conjugates: Methods and Protocols (Methods in Molecular Biology) 1st ed. 2020 Edition
ADC Review | The Bookstore – Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer
ADC Review | The Bookstore – Cytotoxic Payloads for Antibody–Drug Conjugates
ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ADC Review
About
Publications
Onco’Zine
The Onco’Zine Brief
The Onco’Zine Dossier
Episodes
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
Advisory Board
Join Our Editorial Advisory Board
Call for Papers
Submission Guidelines
Instructions for Authors: Introduction
Step 1: Before You Begin the Submission Process
Step 2: Prepare to Submit Your Manuscript
2020 Media Kit
Sponsors
Partners
Feedback
Subscribe
Contact
Articles
Editorial
News
Business & Economics
Conference Coverage
Must Read Articles
Clinical Trials Update
Peer Review
The Review
ADC Directory
Join Today
Video Library
Resources
ADC Drug Map
Resources for Clinicians
ADC Package Inserts
Clinical Trials
ADC University
Recommended Reading
ADC Review | The Bookstore
ADC Review | The Bookstore – Lyophilization of Pharmaceuticals and Biologicals
ADC Review | The Bookstore – Bioconjugation: Methods and Protocols
ADC Review | The Bookstore – Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes
ADC Review | The Bookstore – Analytical Characterization of Biotherapeutics
ADC Review | The Bookstore – Antibody Drug Discovery | Molecular Medicine and Medicinal Chemistry
ADC Review | The Bookstore – Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
ADC Review | The Bookstore – Antibody-Drug Conjugates Methods in Molecular Biology
ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
ADC Review | The Bookstore – Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer 1st Edition
ADC Review | The Bookstore – Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications
ADC Review | The Bookstore – Antibody-Drug Conjugates: Methods and Protocols (Methods in Molecular Biology) 1st ed. 2020 Edition
ADC Review | The Bookstore – Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer
ADC Review | The Bookstore – Cytotoxic Payloads for Antibody–Drug Conjugates
ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
Himalaya Therapeutics to Develop Conditionally Active Biologics for the Greater China Market
ADC Review | Editorial Team
How a CDMO can Support ADC Manufacturing
Lonza Continues Investment in China with New Manufacturing Services Facility in Guangzhou
Sutro’ STRO-002 Receives FDA Fast Track Designation for Patients with Advanced Ovarian Cancer
MabPlex awards CloudWorks4All with Enterprise Resource Planning (ERP) Contract
Advertise with us
MUST READ ARTICLES
Uncialamycin-based ADC Exhinits Unique Bystander Killing Effect
Antibody-drug Conjugates: Coming of Age
How an ADC with Intracellular Drug Release Properties Demonstrates Specific Cytotoxicity...
A&G Pharma and Precision Antibody Identify an Internalizing Target for PTGFRN-positive...
Novel pH Mechanism may Enhance On-Target Effects with Reduced Off-Tumor Toxicity
MORAb-202 has Potential Anti-tumor Effects in Breast Cancer
CONFERENCE COVERAGE
Data for Dose-Escalation Phase 1 Study of Sutro’s STRO-002 Shows Encouraging...
Patritumab Deruxtecan Shows Tumor Response Across Multiple Resistance Mechanisms in Patients...
Astellas and Seagen Submit sBLA for Enfortumab Vedotin in Locally Advanced...
ASH 2020: Preclinical Models Identify CD74 as Potential Target for the...
ASH 2020: ECHELON-1 and ECHELON-2 and other Results with Brentuximab Vedotin
ASH 2020: Positive Interim Phase I Study Results of TRPH-222 in...
NEWS
Sutro’ STRO-002 Receives FDA Fast Track Designation for Patients with Advanced...
MabPlex awards CloudWorks4All with Enterprise Resource Planning (ERP) Contract
Remegen’s Disitamab Vedotin Attracts China’s largest-ever out-license Agreement at US $...
Elucida Submits IND for ELU-001 for the Treatment of Cancers Overexpressing...
Enfortumab Vedotin Receives Regular Approval and an Expanded Indication for Locally...
Novasep and Exelixis Sign Manufacturing Services Agreement for XB002
PEER REVIEW
Addressing the Challenges of Bioconjugate Medicines
How the Next Generation Antibody Drug Conjugates Expands Beyond Cytotoxic Payloads...
Modeling and Optimization of Antibody-drug Conjugate Production Using Process Intensified Solid-phase...
Antibody-drug Conjugates with Novel Kinesin Spindle Protein Inhibitor Payloads and a...
Pharmacokinetic Considerations to Maximize an ADC’s Therapeutic Index
Confocal Microscopy and Imaging Flow Cytometry – Tools for Selection of...
EDITORIAL
Real World-Ready
The Story of World ADC Digital
Annual World ADC – Best New Drug Developer 2020: Sutro Biopharma’s...
Novel Treatments are a Positive Development for Patients with Metastatic Urothelial...
Rapid Advances in the Development of Novel ADCs Targeting B7-H3 and...
World ADC 2019: Maximizing the Clinical Therapeutic Index of Antibody-drug Conjugates
THE REVIEW
Himalaya Therapeutics to Develop Conditionally Active Biologics for the Greater China...
Advisory Committee Votes in Favor of Positive Benefit/Risk Profile for Belantamab...
FDA Accepts Resubmission of Biologics License Application for Sacituzumab Govitecan
Bispecific Antibody Evolution for Cancer Therapy: Advances from Merus, Adimab, Regeneron,...
ADC Express: Rapid ADC Production from a Single Source
What Are Customized ADCs?
Sign up for Our Newsletter
Please enable JavaScript in your browser to complete this form.
Name
*
First
Last
Email
*
GDPR Agreement
*
I consent to having this website store my submitted information so they can respond to my inquiry.
By submitting this form, you are consenting to receive marketing emails from: Sunvalley Communication, publishers of ADC Review and Onco'Zine, 4960 S. Gilbert Road, Suite 1-286, Chandler, AZ 85249, US, https://www.sunvalleycommunication.com You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.
Email
Subscribe to our Newsletter
×
Webinar: TRPH-222 Interim Ph I Data: Leveraging SMARTag® to Enhance Safety
Please enable JavaScript in your browser to complete this form.
Name
*
First
Last
Email
*
Country
*
Select
United States
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua & Deps
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Central African Rep
Chad
Chile
China
Colombia
Comoros
Congo
Congo {Democratic Rep}
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland {Republic}
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea North
Korea South
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar, {Burma}
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Rwanda
St Kitts & Nevis
St Lucia
Saint Vincent & the Grenadines
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tonga
Trinidad & Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
State
*
Select
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Province
*
Please describe your reason for interest:
*
Considering solutions for an immediate need
Evaluating solutions for a project within 6 months
Researching solutions for a project more than 6 months away
No need for a solution, just researching the topic
GDPR Agreement
*
I consent to having this website store my submitted information so they can respond to my inquiry.
Website
Submit
×
X